AstraZeneca’s Farxiga Flies Across $1bn Barrier

Stellar Sales Of SGLT2 Inhibitor

 
• By Kevin Grogan
  
Pascal Soriot
Pascal Soriot • Source: AstraZeneca
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip